111 related articles for article (PubMed ID: 26182481)
1. Measurement of Serum 17α-Hydroxyprogesterone in Infants by Radioimmunoassay.
Muñoz LN; Ochetti M; Perez G; Sobrero GM; Silvano LK; Martin SE; Testa GM; Miras MB
Pediatr Endocrinol Rev; 2015 Jun; 12(4):366-72. PubMed ID: 26182481
[TBL] [Abstract][Full Text] [Related]
2. [Measurement of 17 OH progesterone in blood in Chilean newborns: antecedents for implementing a grogram for the neonatal detection of congenital adrenal hyperplasia].
Cattani A; Reyes ML; Azócar M; Soto J; Romeo E; Valdivia L; Poggi H; Foradori A
Rev Med Chil; 2000 Oct; 128(10):1113-8. PubMed ID: 11349510
[TBL] [Abstract][Full Text] [Related]
3. Serum concentration of 17α-hydroxyprogesterone in children from birth to adolescence.
Ballerini MG; Chiesa A; Morelli C; Frusti M; Ropelato MG
Horm Res Paediatr; 2014; 81(2):118-25. PubMed ID: 24401679
[TBL] [Abstract][Full Text] [Related]
4. Newborn screening for congenital adrenal hyperplasia in Cuba: six years of experience.
González EC; Carvajal F; Frómeta A; Arteaga AL; Castells EM; Espinosa T; Coto R; Pérez PL; Tejeda Y; Del Río L; Segura MT; Almenares P; Robaina R; Fernández JL
Clin Chim Acta; 2013 Jun; 421():73-8. PubMed ID: 23481450
[TBL] [Abstract][Full Text] [Related]
5. Neonatal screening for congenital adrenal hyperplasia.
Barra CB; Silva IN; Pezzuti IL; Januário JN
Rev Assoc Med Bras (1992); 2012; 58(4):459-64. PubMed ID: 22930025
[TBL] [Abstract][Full Text] [Related]
6. [Multicenter investigation on the impact of newborn infants' gestational age and birth weight on the level of 17α-hydroxyprogesterone].
Zhang Q; Wang B; Chen Y; Jiang D; Chen Y
Zhonghua Er Ke Za Zhi; 2014 Sep; 52(9):706-9. PubMed ID: 25476436
[TBL] [Abstract][Full Text] [Related]
7. Cutoff levels of 17-alpha-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight.
van der Kamp HJ; Oudshoorn CG; Elvers BH; van Baarle M; Otten BJ; Wit JM; Verkerk PH
J Clin Endocrinol Metab; 2005 Jul; 90(7):3904-7. PubMed ID: 15797960
[TBL] [Abstract][Full Text] [Related]
8. The influence of seasonality and manufacturer kit lot changes on 17α-hydroxyprogesterone measurements and referral rates of congenital adrenal hyperplasia in newborns.
Pearce M; Dauerer E; DiRienzo AG; Caggana M; Tavakoli NP
Eur J Pediatr; 2017 Jan; 176(1):121-129. PubMed ID: 27900477
[TBL] [Abstract][Full Text] [Related]
9. Serum 17 alpha hydroxyprogesterone in normal full term and preterm vs sick preterm and full term newborns in a tertiary hospital.
Chennuri VS; Mithbawkar SM; Mokal RA; Desai MP
Indian J Pediatr; 2013 Jan; 80(1):21-5. PubMed ID: 22865354
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of CYP21A2 can optimize the follow-up of positive results in newborn screening for congenital adrenal hyperplasia.
Silveira EL; Elnecave RH; dos Santos EP; Moura V; Pinto EM; van der Linden Nader I; Mendonca BB; Bachega TA
Clin Genet; 2009 Dec; 76(6):503-10. PubMed ID: 19930153
[TBL] [Abstract][Full Text] [Related]
11. Neonatal 17-hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening.
Hayashi GY; Carvalho DF; de Miranda MC; Faure C; Vallejos C; Brito VN; Rodrigues AS; Madureira G; Mendonca BB; Bachega TA
Clin Endocrinol (Oxf); 2017 Apr; 86(4):480-487. PubMed ID: 27978607
[TBL] [Abstract][Full Text] [Related]
12. Neonatal screening for congenital adrenal hyperplasia.
van der Kamp HJ; Wit JM
Eur J Endocrinol; 2004 Nov; 151 Suppl 3():U71-5. PubMed ID: 15554889
[TBL] [Abstract][Full Text] [Related]
13. Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants.
Nordenström A; Wedell A; Hagenfeldt L; Marcus C; Larsson A
Pediatrics; 2001 Oct; 108(4):E68. PubMed ID: 11581476
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of 17alpha-hydroxypregnenolone and 17alpha-hydroxyprogesterone in dried blood spots from low birth weight infants using LC-MS/MS.
Higashi T; Nishio T; Uchida S; Shimada K; Fukushi M; Maeda M
J Pharm Biomed Anal; 2008 Sep; 48(1):177-82. PubMed ID: 18571354
[TBL] [Abstract][Full Text] [Related]
15. Corrected 17-alpha-hydroxyprogesterone values adjusted by a scoring system for screening congenital adrenal hyperplasia in premature infants.
Lee JE; Moon Y; Lee MH; Jun YH; Oh KI; Choi JW
Ann Clin Lab Sci; 2008; 38(3):235-40. PubMed ID: 18715851
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal measurements of 17alpha-hydroxyprogesterone in premature infants during the first three months of life.
Linder N; Davidovitch N; Kogan A; Barzilai A; Kuint J; Mazkeret R; Sack J
Arch Dis Child Fetal Neonatal Ed; 1999 Nov; 81(3):F175-8. PubMed ID: 10525018
[TBL] [Abstract][Full Text] [Related]
17. Screening for congenital adrenal hyperplasia: adjustment of 17-hydroxyprogesterone cut-off values to both age and birth weight markedly improves the predictive value.
Olgemöller B; Roscher AA; Liebl B; Fingerhut R
J Clin Endocrinol Metab; 2003 Dec; 88(12):5790-4. PubMed ID: 14671170
[TBL] [Abstract][Full Text] [Related]
18. Weight-adjusted neonatal 17OH-progesterone cutoff levels improve the efficiency of newborn screening for congenital adrenal hyperplasia.
Hayashi G; Faure C; Brondi MF; Vallejos C; Soares D; Oliveira E; Brito VN; Mendonca BB; Bachega TA
Arq Bras Endocrinol Metabol; 2011 Nov; 55(8):632-7. PubMed ID: 22218447
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of congenital adrenal hyperplasia by rapid determination of 17alpha-hydroxyprogesterone in dried blood spots by gas chromatography/mass spectrometry following microwave-assisted silylation.
Deng C; Ji J; Zhang L; Zhang X
Rapid Commun Mass Spectrom; 2005; 19(20):2974-8. PubMed ID: 16178052
[TBL] [Abstract][Full Text] [Related]
20. Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study.
Tsuji A; Konishi K; Hasegawa S; Anazawa A; Onishi T; Ono M; Morio T; Kitagawa T; Kashimada K
BMC Pediatr; 2015 Dec; 15():209. PubMed ID: 26671474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
